Literature DB >> 26611264

Prevalence of multiple sclerosis symptoms across lifespan: data from the NARCOMS Registry.

Robert J Fox1, Tamar E Bacon2, Eric Chamot3, Amber R Salter4, Gary R Cutter4, Jennifer T Kalina2, Ilya Kister2.   

Abstract

The North American Research Committee on Multiple Sclerosis is a voluntary patient registry with more than 38,000 registrants as of 2015. In a recent collaborative project, longitudinal data on patient-perceived impairment in 11 domains commonly affected by multiple sclerosis were examined and tabulated as a function of disease duration. The patterns of disability accumulation differed by domain. Certain symptoms (sensory, fatigue) were particularly prevalent early in the disease. Other symptoms (mobility, hand function, fatigue, bowel/bladder dysfunction, spasticity) were progressively more common with longer disease duration. Some symptoms (vision, cognition, sensory, pain, depression) were relatively common early on in multiple sclerosis, but did not appear to be more frequent with longer disease duration. Ongoing research includes studies of the impact of disease-modifying therapy and symptomatic treatment on patient-perceived impairment over the disease course.

Entities:  

Keywords:  NARCOMS; multiple sclerosis; patient registries; patient-reported outcomes; performance scales

Mesh:

Year:  2015        PMID: 26611264     DOI: 10.2217/nmt.15.55

Source DB:  PubMed          Journal:  Neurodegener Dis Manag        ISSN: 1758-2024


  17 in total

Review 1.  Functional Electrical Stimulation Cycling Exercise for People with Multiple Sclerosis.

Authors:  Lara A Pilutti; Robert W Motl
Journal:  Curr Treat Options Neurol       Date:  2019-11-08       Impact factor: 3.598

Review 2.  Managing Disability in Progressive Multiple Sclerosis.

Authors:  Divyanshu Dubey; Peter Sguigna; Olaf Stüve
Journal:  Curr Treat Options Neurol       Date:  2016-06       Impact factor: 3.598

3.  Identification and validation of clinically meaningful benchmarks in the 12-item Multiple Sclerosis Walking Scale.

Authors:  Myla D Goldman; Melanie D Ward; Robert W Motl; David E Jones; John H Pula; Diego Cadavid
Journal:  Mult Scler       Date:  2016-12-07       Impact factor: 6.312

Review 4.  Multiple Sclerosis-Related Pain Syndromes: An Imaging Update.

Authors:  Amir Mazhari
Journal:  Curr Pain Headache Rep       Date:  2016-12

Review 5.  The Role of Transcranial Magnetic Stimulation as a Surrogate Marker of Disease Activity in Patients with Multiple Sclerosis: A Literature Review.

Authors:  Muhannad M Alsharidah; Mohammad Uzair; Sarah S Alseneidi; Afnan A Alkharan; Reem Fahd Bunyan; Shahid Bashir
Journal:  Innov Clin Neurosci       Date:  2022 Jan-Mar

6.  Sex differences in predictors of illness intrusiveness in persons with multiple sclerosis.

Authors:  Lindsay O Neto; Elizabeth S Gromisch; Jessica Sloan; Tuula Tyry; Frederick W Foley
Journal:  Qual Life Res       Date:  2018-10-17       Impact factor: 4.147

7.  Association Between Serum Vitamin D Levels and Frequency of Relapses in Patients With Multiple Sclerosis.

Authors:  Farah Mansoor; Vikash Kumar; Suneel Kumar; Navneet Kaur; Sidra Naz; Simra Shahid; Faryal Anees; Sidra Memon; Amber Rizwan
Journal:  Cureus       Date:  2021-04-09

Review 8.  Health-Related Quality of Life in Patients with Multiple Sclerosis: Impact of Disease-Modifying Drugs.

Authors:  Peter Joseph Jongen
Journal:  CNS Drugs       Date:  2017-07       Impact factor: 5.749

9.  Examining Multilevel Environmental Correlates of Physical Activity Among Older Adults With Multiple Sclerosis.

Authors:  Stephanie L Silveira; Jessica F Baird; Robert W Motl
Journal:  J Aging Phys Act       Date:  2020-10-13       Impact factor: 1.961

10.  The role of appraisal and coping style in relation with societal participation in fatigued patients with multiple sclerosis: a cross-sectional multiple mediator analysis.

Authors:  Lizanne Eva van den Akker; Heleen Beckerman; Emma Hubertine Collette; Gijs Bleijenberg; Joost Dekker; Hans Knoop; Vincent de Groot
Journal:  J Behav Med       Date:  2016-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.